Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
PURPOSE: This meta-analysis examined roles of several metabolites in differentiating recurrent tumor from necrosis in patients with brain tumors using MR perfusion and spectroscopy. METHODS: Medline, Cochrane, EMBASE, and Google Scholar were searched for studies using perfusion MRI and/or MR spectroscopy published up to March 4, 2015 which differentiated between recurrent tumor vs. necrosis in patients with primary brain tumors or brain metastasis. Only two-armed, prospective or retrospective studies were included. A meta-analysis was performed on the difference in relative cerebral blood volume (rCBV), ratios of choline/creatine (Cho/Cr) and/or choline/N-acetyl aspartate (Cho/NAA) between participants undergoing MRI evaluation. A χ2-based test of homogeneity was performed using Cochran's Q statistic and I2. RESULTS: Of 397 patients in 13 studies who were analyzed, the majority had tumor recurrence. As there was evidence of heterogeneity among 10 of the studies which used rCBV for evaluation (Q statistic = 31.634, I2 = 97.11%, P < 0.0001) a random-effects analysis was applied. The pooled difference in means (2.18, 95%CI = 0.85 to 3.50) indicated that the average rCBV in a contrast-enhancing lesion was significantly higher in tumor recurrence compared with radiation injury (P = 0.001). Based on a fixed-effect model of analysis encompassing the six studies which used Cho/Cr ratios for evaluation (Q statistic = 8.388, I2 = 40.39%, P = 0.137), the pooled difference in means (0.77, 95%CI = 0.57 to 0.98) of the average Cho/Cr ratio was significantly higher in tumor recurrence than in tumor necrosis (P = 0.001). There was significant difference in ratios of Cho to NAA between recurrent tumor and necrosis (1.02, 95%CI = 0.03 to 2.00, P = 0.044). CONCLUSIONS: MR spectroscopy and MR perfusion using Cho/NAA and Cho/Cr ratios and rCBV may increase the accuracy of differentiating necrosis from recurrent tumor in patients with primary brain tumors or metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Verma, N., Cowperthwaite, M. C., Burnett, M. G., & Markey, M. K. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos307 · Cited by 351 · cited 2×
“These functional imaging techniques include CT perfusion, MR perfusion [11–15], diffusion weighted imaging (DWI)[2, 3], MR spectroscopy [12, 14, 16–22] single-photon emission computed tomography (SPECT) [23, 24], and positron emission tomography (PET) [25–27].”
BackgroundMethodBarajas, R., Chang, J. S., Sneed, P. K., Segal, M. R., McDermott, M. W., & Cha, S. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1362 · Cited by 278 · cited 1×
“Necrosis 21 62 57% Barajas (2009)[15] Retrospective Metastatic brain tumor NA Either confirmed histologically or clinicoradiologically, with serial MR follow-up every 1–3 months.”
BackgroundRadiation Necrosis in the Brain: Imaging Features and Differentiation from Tumor Recurrence
Shah, R., Vattoth, S., Jacob, R., Manzil, F. F. P., O’Malley, J. P., Borghei, P., Patel, B. N., & Curé, J. K. (2012) · RadioGraphics · doi:10.1148/rg.325125002 · Cited by 258
Hu, L. S., Eschbacher, J. M., Heiserman, J. E., Dueck, A. C., Shapiro, W. R., Liu, S., Karis, J. P., Smith, K. A., Coons, S. W., Nakaji, P., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos112 · Cited by 216
Mitsuya, K., Nakasu, Y., Horiguchi, S., Harada, H., Nishimura, T., Bando, E., Okawa, H., Furukawa, Y., Hirai, T., & Endo, M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0106-z · Cited by 205 · cited 2×
“Conventional MRI does not provide sufficient information to differentiate delayed radiation effects from tumor recurrence, whereas PET, MR spectroscopy, and other modalities can lead to false positive findings of tumor recurrence [13].”
BackgroundPrager, A. J., Martinez, N., Beal, K., Omuro, A., Zhang, Z., & Young, R. J. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4218 · Cited by 193 · cited 1×
“Prager (2015)[35] Retrospective Primary glioblastoma or anaplastic astrocytoma NA Histopathology at repeat surgical excision 1.”
BackgroundProton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.
Schlemmer, H., Bachert, P., Herfarth, K. K., ZUNA, I., Debus, J., & KAICK, G. V. (2001) · PubMed · Cited by 180
Nelson, S. J. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1669 · Cited by 105 · cited 3×
“These functional imaging techniques include CT perfusion, MR perfusion [11–15], diffusion weighted imaging (DWI)[2, 3], MR spectroscopy [12, 14, 16–22] single-photon emission computed tomography (SPECT) [23, 24], and positron emission tomography (PET) [25–27].”
BackgroundMethodNakajima, T., Kumabe, T., Kanamori, M., Saito, R., Tashiro, M., Watanabe, M., & Tominaga, T. (2009) · Neurologia medico-chirurgica · doi:10.2176/nmc.49.394 · Cited by 73
Enslow, M. S., Zollinger, L. V., Morton, K. A., Butterfield, R. I., Kadrmas, D. J., Christian, P. E., Boucher, K. M., Heilbrun, M. E., Jensen, R. L., & Hoffman, J. M. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318262c76a · Cited by 67
Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm.
Krouwer, H. G. J., Kim, T. A., Rand, S. D., et al. (1998) · PubMed · Cited by 66
Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
Thompson, G., Mills, S. J., Coope, D. J., O’connor, J. P. B., & Jackson, A. (2011) · The British Journal of Radiology · doi:10.1259/bjr/66316279 · Cited by 61
11C-MET PET/CT and Advanced MRI in the Evaluation of Tumor Recurrence in High-Grade Gliomas
D'Souza, M. M., Sharma, R., Jaimini, A., Panwar, P., Saw, S. K., Kaur, P., Mondal, A., Mishra, A. K., & Tripathi, R. P. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000532 · Cited by 61
MRI patterns of T 1 enhancing radiation necrosis versus tumour recurrence in high‐grade gliomas
Reddy, K., Westerly, D., & Chen, C. (2013) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2012.02472.x · Cited by 51
Cited by
Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx221 · Cited by 637
Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.016 · Cited by 592
Primary brain tumours in adults
van den Bent, M. J., Geurts, M., French, P. J., Smits, M., Capper, D., Bromberg, J. E. C., & Chang, S. M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01054-1 · Cited by 419
Metadata
- Authors
- Chuang, M.-T., Liu, Y.-S., Tsai, Y.-S., Chen, Y.-C., & Wang, C.-K.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-07
- Volume
- 11
- Issue
- 1
- Pages
- e0141438
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2224084268
- Cited by
- 158
- References
- 18
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.